These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 30742321)
1. The clinical role of LASER for vulvar and vaginal treatments in gynecology and female urology: An ICS/ISSVD best practice consensus document. Preti M; Vieira-Baptista P; Digesu GA; Bretschneider CE; Damaser M; Demirkesen O; Heller DS; Mangir N; Marchitelli C; Mourad S; Moyal-Barracco M; Peremateu S; Tailor V; Tarcan T; De EJB; Stockdale CK Neurourol Urodyn; 2019 Mar; 38(3):1009-1023. PubMed ID: 30742321 [TBL] [Abstract][Full Text] [Related]
2. The Clinical Role of LASER for Vulvar and Vaginal Treatments in Gynecology and Female Urology: An ICS/ISSVD Best Practice Consensus Document. Preti M; Vieira-Baptista P; Digesu GA; Bretschneider CE; Damaser M; Demirkesen O; Heller DS; Mangir N; Marchitelli C; Mourad S; Moyal-Barracco M; Peremateu S; Tailor V; Tarcan T; De EJB; Stockdale CK J Low Genit Tract Dis; 2019 Apr; 23(2):151-160. PubMed ID: 30789385 [TBL] [Abstract][Full Text] [Related]
3. The evidence behind the use of LASER for genitourinary syndrome of menopause, vulvovaginal atrophy, urinary incontinence and lichen sclerosus: A state-of-the-art review. Mortensen OE; Christensen SE; Løkkegaard E Acta Obstet Gynecol Scand; 2022 Jun; 101(6):657-692. PubMed ID: 35484706 [TBL] [Abstract][Full Text] [Related]
5. Re: The Clinical Role of LASER for Vulvar and Vaginal Treatments in Gynecology and Female Urology: An ICS/ISSVD Best Practice Consensus Document. Wein AJ J Urol; 2019 Nov; 202(5):871-872. PubMed ID: 31408422 [No Abstract] [Full Text] [Related]
6. IUGA committee opinion: laser-based vaginal devices for treatment of stress urinary incontinence, genitourinary syndrome of menopause, and vaginal laxity. Shobeiri SA; Kerkhof MH; Minassian VA; Bazi T; Int Urogynecol J; 2019 Mar; 30(3):371-376. PubMed ID: 30523374 [TBL] [Abstract][Full Text] [Related]
7. LASER users' expert opinion in response to "The clinical role of LASER for vulvar and vaginal treatments in gynecology and female urology: An ICS/ISSVD best practice consensus document". Salvatore S; Athanasious S; Yuen HTH; Karram M Neurourol Urodyn; 2019 Nov; 38(8):2383-2384. PubMed ID: 31432545 [No Abstract] [Full Text] [Related]
8. Editorial Comment: The clinical role of LASER for vulvar and vaginal treatments in gynecology and female urology: An ICS/ISSVD best practice consensus document. Riccetto CLZ Int Braz J Urol; 2020; 46(3):469-470. PubMed ID: 32167719 [No Abstract] [Full Text] [Related]
9. Comments on Preti et al: "The clinical role of LASER for vulvar and vaginal treatments in gynecology and female urology: An ICS/ISSVD best practice consensus document". Gambacciani M Neurourol Urodyn; 2019 Sep; 38(7):2010-2011. PubMed ID: 31436354 [No Abstract] [Full Text] [Related]
10. Response letter to comments related to "The clinical role of LASER for vulvar and vaginal treatments in gynecology and female urology: An ICS/ISSVD best practice consensus document". Digesu GA; Vieira-Baptista P; Tailor V; Stockdale C; Preti M Neurourol Urodyn; 2020 Jan; 39(1):473-476. PubMed ID: 31765486 [No Abstract] [Full Text] [Related]
11. Laser therapy for the restoration of vaginal function. Gambacciani M; Palacios S Maturitas; 2017 May; 99():10-15. PubMed ID: 28364861 [TBL] [Abstract][Full Text] [Related]
12. The energy based devices for vaginal "rejuvenation," urinary incontinence, vaginal cosmetic procedures, and other vulvo-vaginal disorders: An international multidisciplinary expert panel opinion. Digesu GA; Tailor V; Preti M; Vieira-Baptista P; Tarcan T; Stockdale C; Mourad S Neurourol Urodyn; 2019 Mar; 38(3):1005-1008. PubMed ID: 30697814 [TBL] [Abstract][Full Text] [Related]
13. European Board and College of Obstetrics and Gynaecology (EBCOG) position statement on the use of laser vaginal devices for treatment of genitourinary syndrome of menopause, vaginal laxity, pelvic organ prolapse and stress urinary incontinence. Giarenis I; Tsiapakidou S; Zacche M; Mukhopadhyay S; Mahmood T Eur J Obstet Gynecol Reprod Biol; 2024 Aug; 299():342-344. PubMed ID: 38811292 [TBL] [Abstract][Full Text] [Related]
14. Dynamic quadripolar radiofrequency treatment of vaginal laxity/menopausal vulvo-vaginal atrophy: 12-month efficacy and safety. Vicariotto F; DE Seta F; Faoro V; Raichi M Minerva Ginecol; 2017 Aug; 69(4):342-349. PubMed ID: 28608667 [TBL] [Abstract][Full Text] [Related]
15. Applicability of vaginal energy-based devices in urogynecology: evidence and controversy. Machado AC; Judice LMDPP; Riccetto CLZ; Toledo LGM Rev Assoc Med Bras (1992); 2023; 69(suppl 1):e2023S129. PubMed ID: 37556648 [TBL] [Abstract][Full Text] [Related]
16. Technological evolution in the radiofrequency treatment of vaginal laxity and menopausal vulvo-vaginal atrophy and other genitourinary symptoms: first experiences with a novel dynamic quadripolar device. Vicariotto F; Raichi M Minerva Ginecol; 2016 Jun; 68(3):225-36. PubMed ID: 27206062 [TBL] [Abstract][Full Text] [Related]
17. Rationale and design for fractional microablative CO Flint R; Cardozo L; Grigoriadis T; Rantell A; Pitsouni E; Athanasiou S Climacteric; 2019 Jun; 22(3):307-311. PubMed ID: 30676818 [TBL] [Abstract][Full Text] [Related]